Truist Financial Corp Ultragenyx Pharmaceutical Inc. Transaction History

Truist Financial Corp

$65 Billion
Q2 2024

A detailed history of Truist Financial Corp transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Truist Financial Corp holds 9,791 shares of RARE stock, worth $532,924. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,791

Previous 10,110 3.16%

Holding current value

$532,924

Previous $472,000 14.83%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 20, 2024	SELL	$37.42 - $51.61 $11,936 - $16,463	-319 Reduced 3.16%	9,791 $402,000
Q1 2024 May 10, 2024	SELL	$43.02 - $53.69 $69,391 - $86,601	-1,613 Reduced 13.76%	10,110 $472,000
Q4 2023 Feb 02, 2024	SELL	$31.73 - $49.19 $231,343 - $358,644	-7,291 Reduced 38.35%	11,723 $560,000
Q3 2023 Nov 14, 2023	SELL	$34.92 - $46.66 $20,917 - $27,949	-599 Reduced 3.05%	19,014 $677,000
Q2 2023 Aug 01, 2023	BUY	$37.35 - $52.15 $176,516 - $246,460	4,726 Added 31.75%	19,613 $904,000
Q1 2023 May 05, 2023	BUY	$36.99 - $48.71 $24,228 - $31,905	655 Added 4.6%	14,887 $596,000
Q4 2022 Feb 17, 2023	BUY	$33.72 - $46.33 $91,381 - $125,554	2,710 Added 23.52%	14,232 $659,000
Q3 2022 Oct 26, 2022	BUY	$39.96 - $66.14 $155,164 - $256,821	3,883 Added 50.83%	11,522 $477,000
Q2 2022 Jul 22, 2022	SELL	$45.8 - $85.4 $2,977 - $5,551	-65 Reduced 0.84%	7,639 $456,000
Q1 2022 Apr 22, 2022	BUY	$62.2 - $84.4 $81,979 - $111,239	1,318 Added 20.64%	7,704 $559,000
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $515 - $615	7 Added 0.11%	6,386 $537,000
Q3 2021 Nov 05, 2021	BUY	$77.92 - $102.4 $15,194 - $19,968	195 Added 3.15%	6,379 $575,000
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $29,777 - $37,374	-323 Reduced 4.96%	6,184 $590,000
Q1 2021 May 17, 2021	BUY	$106.9 - $167.73 $41,797 - $65,582	391 Added 6.39%	6,507 $741,000
Q4 2020 Nov 19, 2021	SELL	$84.4 - $177.39 $379,968 - $798,609	-4,502 Reduced 42.4%	6,116 $846,000
Q4 2020 Feb 18, 2021	BUY	$84.4 - $177.39 $452,806 - $951,697	5,365 Added 102.13%	10,618 $1.47 Million
Q3 2020 Nov 13, 2020	BUY	$72.98 - $90.0 $47,728 - $58,860	654 Added 14.22%	5,253 $432,000
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $215,739 - $359,733	4,599 New	4,599 $360,000

Others Institutions Holding RARE

# of Institutions

287

Shares Held

88.1M

Call Options Held

505K

Put Options Held

198K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.81B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Ultragenyx Pharmaceutical Inc. Transaction History